BioNTech (BNTX)
BioNTech stock today
BioNTech closed at $88.17 on October 30, 2026, down 1.08% on the day. Over the past year it returned -15.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $22.3 billion.
| Period | BNTX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -10.3% | -0.9% |
| 3 months | -5.0% | +2.1% |
| Year to date | -7.4% | +11.7% |
| 1 year | -15.8% | +12.4% |
| 3 years | -5.4% | +88.5% |
| 5 years | -67.6% | +76.0% |
Key statistics
- Market value
- $22.3B
- Price / sales
- 7.2
- 52-week range
- $83.89 to $119.34
- Next report
- Nov 3, 2026
About BioNTech
Develops and manufactures messenger RNA-based vaccines and therapeutics.
Sector: Health Care · Industry: Biotechnology
More on BioNTech
- Financials: revenue, earnings and segmentsRevenue +18% in the year to Dec 2025
- Valuation: P/E history and peers
- Returns: what $1,000 became$1,000 five years ago is $323.59 today
No forecast, no recommendation. This page describes BioNTech from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.